2012
DOI: 10.1016/j.neuron.2012.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain

Abstract: SUMMARY We used affinity-purification mass spectrometry to identify 747 candidate proteins that are complexed with Huntingtin (Htt) in distinct brain regions and ages in Huntington’s disease (HD) and wildtype mouse brains. To gain a systems-level view of the Htt interactome, we applied Weighted Gene Correlation Network Analysis (WGCNA) to the entire proteomic dataset to unveil a verifiable rank of Htt-correlated proteins and a network of Htt-interacting protein modules, with each module highlighting distinct a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
262
0
2

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 269 publications
(288 citation statements)
references
References 67 publications
15
262
0
2
Order By: Relevance
“…Inclusions disappear when huntingtin expression is blocked [108]. Multiple lines of evidence suggest that polyQ expanded proteins titrate chaperones away from their clients, leading to proteostasis impairment [44,74,100,109,110]. Conversely, overexpression of various chaperones, such as members of the Hsp70 system, suppresses polyQ toxicity [3, 69,75].…”
Section: Resultsmentioning
confidence: 99%
“…Inclusions disappear when huntingtin expression is blocked [108]. Multiple lines of evidence suggest that polyQ expanded proteins titrate chaperones away from their clients, leading to proteostasis impairment [44,74,100,109,110]. Conversely, overexpression of various chaperones, such as members of the Hsp70 system, suppresses polyQ toxicity [3, 69,75].…”
Section: Resultsmentioning
confidence: 99%
“…We have shown that 14‐3‐3 overexpression, particularly 14‐3‐3 θ , is protective in neurotoxin, α syn, and LRRK2 models of PD, while 14‐3‐3 inhibition promotes toxicity in these models 5, 15, 16, 17. 14‐3‐3s also interact with proteins implicated in other neurodegenerative disorders, including beta‐amyloid (A β ), tau, superoxide dismutase, and huntingtin 18, 19, 20, 21, 22. 14‐3‐3s colocalize with these aggregation‐prone proteins in neurofibrillary tangles and plaques of Alzheimer's disease (AD), Huntington's disease (HD) inclusion bodies, and inclusions observed in amyotrophic lateral sclerosis (ALS) 20, 23, 24, 25…”
Section: Introductionmentioning
confidence: 99%
“…Recently, proteomic studies to identify HTT-associated proteins have also been done in the context of full-length HTT expressed in mouse brain, using affinity purificationmass spectrometry [112,113]. Using subcellular fractionation of brain homogenates, one study found molecular chaperones as mutant HTT interactors, in support of previous findings and highlighting the central role of these folding machineries as HTT modifiers [112].…”
Section: Proteomic Screeningmentioning
confidence: 66%
“…Interestingly, although the majority of HTT interactors were relatively conserved across different brain tissue and age, brain region-and developmental stage-specific interactors were also found, suggesting that some of these proteins might contribute to the selective neuronal susceptibility and age-dependent degeneration observed in HD patients. A comparison to other proteomic datasets reported previously [53,111,115] showed greater overlap among HTT datasets than between HTT and ataxia datasets, suggesting that unique protein-protein interactions may contribute to specific pathogenic mechanisms in different, but related, polyQ-mediated diseases [113].…”
Section: Proteomic Screeningmentioning
confidence: 75%
See 1 more Smart Citation